Correlation Between Cue Biopharma and BriaCell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Cue Biopharma and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and BriaCell Therapeutics.
Diversification Opportunities for Cue Biopharma and BriaCell Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cue and BriaCell is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and BriaCell Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and BriaCell Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to generate 0.79 times more return on investment than BriaCell Therapeutics. However, Cue Biopharma is 1.27 times less risky than BriaCell Therapeutics. It trades about 0.0 of its potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.0 per unit of risk. If you would invest 308.00 in Cue Biopharma on September 2, 2024 and sell it today you would lose (186.00) from holding Cue Biopharma or give up 60.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.19% |
| Values | Daily Returns |
Cue Biopharma vs. BriaCell Therapeutics Corp
Performance |
| Timeline |
| Cue Biopharma |
| BriaCell Therapeutics |
Cue Biopharma and BriaCell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and BriaCell Therapeutics
The main advantage of trading using opposite Cue Biopharma and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| BriaCell Therapeutics vs. Briacell Therapeutics Corp | BriaCell Therapeutics vs. GeoVax Labs | BriaCell Therapeutics vs. immatics biotechnologies GmbH | BriaCell Therapeutics vs. CannBioRx Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |